Skip to main content
OpenTrials
Completed

NCT Number: NCT01648530

Chronic Migraine Epidemiology and Outcomes Study

This is a population internet-based study to characterize migraine clinical course and impact on family.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of migraine
  • U.S. Member of Survey Panel
  • Household member of study participant
  • Ability to complete internet-based questionnaires

Exclusion criteria

  • No access to internet

Treatment and study plan

No treatment

Other

No Treatment

Primary outcomes

  1. Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM)

    Time frame: Baseline

    EM is defined as <15 headache days/month and CM is defined as ≥15 headache days/month.

  2. Migraine Disability Assessment (MIDAS)

    Time frame: 12 Months

    The Midas score is a patient completed 5-item questionnaire about lost time and productivity (for work, school or family/social activities) in the past 3 months (number of days missed) where: 0-5=Little or No disability, 6-10=Mild disability, 11-20=Moderate disability or 21+ Severe disability. The Midas scores assessed at Months 3, 6, 9 and 12 were averaged.

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jul 24, 2012
Registry last updated
Jan 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.